Is Your Portfolio Healthy? Don't Touch This Stock With a Ten-Foot Pole!
Amidst lingering economic uncertainties, pharma contract development company Avid Bioservices (CDMO) has been flashing red flags with deteriorating financial results in the last reported quarter and bleak prospects. Therefore, I…
